The Aspirin Alternative Your Doctor Never Told You About
Posted June 29th 2015 Written
By: Sayer Ji, Founder
Millions use aspirin daily without realizing its true dangers. The
good news is that there is a natural alternative which preliminary research
indicates is safer and more effective.
WARNING:
Never discontinue a pharmaceutical product without the guidance of a physician.
Doing so could have serious, if not life threatening side effects. This article
is for informational purposes only. Nothing here is intended as or should be
substituted for medical advice.
Aspirin is taken faithfully by millions every
day as a preventive measure against heart attack, often without the user having
any awareness of the serious health risks associated with it, some potentially fatal. You can view over 60
adverse effects of aspirin on the GreenMedInfo.com'saspirin research page if you have any doubts about how serious a concern this is.
Aspirin's widespread popularity is based on its
much-touted blood-thinning properties. But there are safer, surprisingly more
effective and far more natural alternatives on the market today.
For instance, pycnogenol, a branded form of an
extract of French maritime pine bark, can be found on the shelves of thousands
of health food stores around the country, and unique among natural products,
has a broad base of human clinical research supporting its use for a wide
variety of health conditions. You can view GreenMedInfo.com's pycnogenol research page take a
look at the published research.
Moreover, in cross comparison tests, pycnogenol
has been found at least as effective as aspirin in preventing blood from
clotting, but at significantly lower doses and with a superior safety profile.
Smoker's Study Proves Pycnogenol
More Effective and Safer Than Aspirin
In a previous article titled, "The Powerful Aspirin Alternative
That Grows on Trees," we featured a 1999
clinical study published in Thrombotic Research that found that when habitual
smokers were given either 500 mg of aspirin or anywhere between 100-200 mg of
pycnogenol, the pycnogenol group experienced equivalent platelet aggregation
inhibiting effects but with much lower bleeding times:
"Thus,
smoking-induced enhanced platelet aggregation was inhibited by 500 mg Aspirin
as well as by a lower range of 100-125 mg Pycnogenol. Aspirin significantly
(p<0 .001="" 167="" 236="" advantageous="" an="" bleeding="" did="" for="" from="" increased="" nbsp="" not.these="" o:p="" observations="" pycnogenol.="" pycnogenol="" ratio="" risk-benefit="" seconds="" suggest="" time="" to="" while="">0>
This is a highly significant finding, as
aspirin-induced bleeding can result in significantly increased morbidity and
mortality. One might ask, if pycnogenol is as effective a 'blood thinner'
as aspirin but without the same side effects, then what is the downside of
using the natural alternative?
New Study Confirms Pycnogenol's
Superiority to Aspirin
Research comparing pycnogenol to aspirin as a
blood thinner has been sparse, but a new study promises to add additional
weight to the previously reported finding of pycnogenol's superiority.
Published this year in the Italian journal Panminerva
Medica and titled, "Recurrence of retinal vein thrombosis with Pycnogenol®
or Aspirin® supplementation: a registry study,"
researchers compared the use of either pycnogenol or aspirin in the
prevention of retinal vein thrombosis recurrence after a first
episode.
Retinal vein thrombosis is considered to be a
relatively common condition intimately related to other conditions that afflict
the vascular system, such as hypertension, arteriosclerosis and diabetes.[1]
The study
methods were described as follows:
Possible management options -
chosen by patients - were: standard management; standard management +
oral Aspirin® 100 mg once/day (if there were no tolerability problems
before admission); standard management + Pycnogenol® two 50 mg capsules
per day (for a total of 100 mg/day). Number of subjects, age, sex, distribution,
percentage of smokers, and visThe
results were reported as follows:
Recurrent RVT was seen in
17.39% of controls and in 3.56% of subjects supplemented with Pycnogenol®
(P<0 .05="" 15.38="" 26="" 2="" 4.32="" 4.88="" 6="" 7.69="" 9="" a="" also="" and="" antiplatelets="" at="" be="" better="" compared="" comparison="" completed="" controls="" does="" dropped="" during="" edema="" effects.="" episodes="" equivalent="" follow-up="" for="" good="" group="" groups.="" has="" hemorrhagic="" higher="" in="" incidence="" indicates="" induce="" it="" level="" linked="" lower="" management="" may="" minor="" months="" nbsp="" new="" nine="" not="" o:p="" observed="" of="" or="" other="" out="" p="" pilot="" problems.="" profile.="" recurrence="" reduce="" reduced="" registry="" retinal="" rvt="" safety="" seems="" side="" significantly="" spirin="" standard="" subclinical="" subjects="" supplement="" supplementation="" that="" the="" theoretically="" there="" this="" times="" to="" tolerability="" use="" using="" very="" vision="" vs.="" was="" were="" with="" without="" ycnogenol="">0>
As you can see, the clear winner in this
comparison study was pycnogenol. Not only was the incidence of recurrent
retinal vein thrombosis almost five times higher in the aspirin group, vision
and retinal swelling (edema) was significantly lower in the pycnogenol group,
as well. Moreover, whereas the pycnogenol group had no reported side effects, 6
of the 26 subjects in the aspirin group dropped out due to tolerability issues,
and 7.69% of the aspirin group (2 subjects of 26) were found to have retinal
bleeding as a side effect in the follow-up period.
Nature Provides Time-Tested
Solutions
We really shouldn't be surprised that a
naturally occurring complex of phytocompounds (i.e. pycnogenol) should
outperform a synthetic drug, considering that our bodies have co-evolved for
millions of years with natural things, (e.g. foods, herbs, spices), and only a
hundred or more with synthetic ones, (e.g. patent drugs). Pycnogenol, as a bark
extract, is about 65-75 percent proanthocyanidins (procyanidins), a class of
polyphenols found in a wide variety of plants, many of which have been in the
human diet since the inception of our species and before. Some classical
examples include green and black tea, cranberry, bilberry, cocoa beans,
cinnamon, and black currant. Polyphenols, of course, are powerful antoxidants,
as well as signaling molecules, which likely perform a variety of
gene-regulatory functions, that may have value in a wide range of health
conditions. Indeed, we have indexed over 150 health benefits linked to polyphenol consumption on
our database alone.
Suffice it to say that as the biomedical machine
moves forward, and we see an increasingly voluminous body of literature investigating
the health benefits and mechanisms of action underpinning natural interventions
for disease prevention and treatment, we will
become increasingly compelled to choose time-tested, natural alternatives to
synthetic chemicals, as the former are not only much safer but often more
effective than most scientists and physicians ever dreamed possible.
Additional References [1] Prisco D, Marcucci R. Retinal vein thrombosis: risk
factors, pathogenesis and therapeutic approach. Pathophysiol
Haemost Thromb. 2002 Sep-Dec;32(5-6):308-11. Review. PubMed PMID: 13679663.